| 今开：3.45 | 昨收：3.41 |
| 最高：3.52 | 最低：3.14 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：8.6715467E7 |
chuminhua04-23 11:46
4/22，Abeona Therapeutics $Abeona Therapeutics(ABEO)$ 表示，其针对隐性营养不良性大疱性表皮松解症 (DEB) 患者的自体基因校正细胞疗法 prademagene zamikeracel (pz-cel) 收到了 FDA 的完整回复信 (CRL)。 该公司股价周一盘后交易中暴跌 51%。
FDA 表示，Abeona 必须满足额外的CMC 要求才...查看全文
Abeona Therapeutics(ABEO)02-15 05:25
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000200 Act: 34 Size: 47 KB 网页链接查看全文
Abeona Therapeutics(ABEO)03-16 05:05
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-010132 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)02-15 05:55
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023895 Act: 34 Size: 59 KB 网页链接查看全文
Abeona Therapeutics(ABEO)02-07 21:35
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-005208 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)02-13 06:25
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193805-24-000176 Act: 34 Size: 104 KB 网页链接查看全文
Abeona Therapeutics(ABEO)03-18 20:45
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-010206 Act: 34 Size: 292 KB 网页链接查看全文
Abeona Therapeutics(ABEO)04-23 04:15
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-015531 Act: 34 Size: 244 KB 网页链接查看全文
Abeona Therapeutics(ABEO)02-15 03:45
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001247 Act: 34 Size: 91 KB 网页链接查看全文
Abeona Therapeutics(ABEO)03-19 19:25
$Abeona Therapeutics(ABEO)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-010421 Act: 34 Size: 1 MB 网页链接查看全文
智通财经APP获悉，11月27日，Abeona Therapeutics(ABEO.US)宣布，美国FDA已接受其在研疗法pz-cel(prademagene zamikeracel，EB-101)的生物制品许可申请(BLA)，并授予优先审评资格，该疗法是一款自体、COL7A1基因校正表皮片，用于隐性... 网页链接
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001493152-24-015792 Act: 34 Size: 236 KB 网页链接
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-015531 Act: 34 Size: 244 KB 网页链接
$Abeona Therapeutics(ABEO)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-010421 Act: 34 Size: 1 MB 网页链接
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-010206 Act: 34 Size: 292 KB 网页链接
$Abeona Therapeutics(ABEO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-010190 Act: 34 Size: 8 MB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-010132 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-009682 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023895 Act: 34 Size: 59 KB 网页链接
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000200 Act: 34 Size: 47 KB 网页链接
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001713 Act: 34 Size: 62 KB 网页链接